Beijing

Dr. Werner Heil co-founded Beijing Huade Haiyang Science & Technology Co., Ltd. Previously, he was Vice President for Strategy and Intelligence of Degussa in China where he provided the board of management in Germany and the business units with business, technical, and financial intelligence on Chinese/foreign companies also related to competitors' R&D and innovation efforts. Dr. Heil had responsibility for takeover activities and legal issues in China.

Prior to this, Dr. Heil worked for BCG. Clients include the chemical, pharmaceutical and chemical engineering industry. Assignments include product portfolio restructuring as well as acquisition target analysis, among others.

He holds a Ph.D. in Technical Chemistry and a master of chemistry from the University of Kiel, Germany, and speaks Chinese (Mandarin & Cantonese), English, German. Mr. Heil received management education from INSEAD and the Canadian Institute of Competitive Intelligence in Asian Strategy, Corporate Finance and Competitve Intelligence.

Affiliations:

  • Director of Zylon Bioplastics Shd., Bhd., Kuala Lumpur, Malaysia
  • Director of Beijing Jianli Pharmaceuticals Co., Ltd., P.R. China
  • Partner & Consultant of JANUS Gesellschaft für Sicherheit in der Wirtschaft mbH, Frankfurt am Main, Germany, (Security and Investigations)
  • Corporate Member of SCIC (Society of Chinese Intelligence Professionals)
  • Member of SCIP (Society of Competitve Intelligence Professionals, United States)
  • Member of various industry associations in China
  • Alumni of the German National Academic Foundation (Studienstiftung des deutschen Volkes)
  • Alumni of BCG (The Boston Consulting Group)

Email: heil@heilyang.com